Use of pet-ct in radiotherapic gliomas planning
International Journal of Development Research
Use of pet-ct in radiotherapic gliomas planning
Received 23rd April, 2018; Received in revised form 11th May, 2018; Accepted 24th June, 2018; Published online 30th July, 2018
Copyright © 2018, Tridibesh Tripathy and Anjali Tripathy. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The use of positron emission computed tomography in radiotherapy planning has increased over the last decade. In this study, we analyzed, through a bibliographic research, the use of positron emission computed tomography examination in radiotherapy of gliomas. The research was conducted from October to November 2017, in the databases of "VHL", "Science Direct", "Pubmed" and "Web of Science", through the married descriptors: Positron Emission Tomography Computed Tomography OR pet AND Radiotherapy AND Planning and was constituted of 14 articles published in the period from 2013 to 2017. The literature has shown that the positron emission computed tomography technique when used for the radiotherapy of gliomas allows a safer treatment in the delivery of the dose in the delimited structures, thus saving the normal tissue, reducing the toxicity and reducing the probability of geographical errors in the definition of the target volume, thus having the potential to impact many aspects of the therapeutic approach. It was also noticed the increase of research related to the radiopharmaceuticals used in this examination, emphasizing the importance of further studies related to the topic.
